ArticlesAbstractPharmacognosy Research,2025,17,4,1187-1196.DOI:10.5530/pres.20252214Published:August 2025Type:Original ArticleAuthors:Thachan Sreelakshmi, Meethaley Valappil Jeeshna, Abhijith Sarga, and Sugunan Ashitha Author(s) affiliations:Thachan Sreelakshmi*, Meethaley Valappil Jeeshna , Abhijith Sarga, Sugunan Ashitha Department of Botany, Sree Narayana College, Kannur, Kerala, INDIA. Abstract:The presence of the phytochemical constituents has been reported from species of the Linderniaceae family. Objectives: The present study was designed to determine the bioactive compounds in the whole plant extracts of Bonnaya ciliata (Colsm.) Spreng. and Torenia crustacea (L.) Cham. and Schltdl. Materials and Methods: Phytochemical screening of these plants revealed the presence of several bioactive components. Liquid Chromatography Mass Spectrometry (LCMS) analysis of the ethanolic extracts was performed using LCMS equipment. Results: The phytochemical tests revealed the presence of several bioactive compounds. Utilizing qualitative analysis alongside advanced LC-MS profiling, we aimed to uncover the range of bioactive compounds these species contain. Our qualitative assessments revealed a rich array of secondary metabolites, including phenolic compounds, flavonoids, and glycosides, indicating significant bioactive potential. The LC-MS analysis further identified key constituents such as Aloesin, Luteolin-7-glucoside, Rhodioloside, and Kaempferol-3-O-glucoside, which are known for their antioxidant, anti-inflammatory, and antimicrobial properties. These findings highlight the therapeutic significance of Bonnaya ciliata (Colsm.) Spreng. and Torenia crustacea (L.) Cham. and Schltdl, suggesting their potential as sources of natural remedies. Conclusion: The findings suggest that by combining qualitative and quantitative approaches, this research provides a foundation for future studies aimed at developing plant-based solutions for health and wellness. Keywords:Bonnaya ciliata, Linderniaceae, Phytochemical, Plant-based drug discovery, Torenia crustaceaView:PDF (500.49 KB) PDF Thumbnails Document Outline Search Document Find Toggle Sidebar Previous Next Page: Fullscreen Print Download Current View Zoom Out Zoom In Automatic Zoom Actual Size Fit Page Full Width 50% 75% 100% 125% 150% 200% More Information Less Information Close Click here to download the PDF file. Images Extraction of phytocompounds for LCMS analysis: A comprehensive overview. Ona, S. (2022) BioRender. Ona, S. (2022). KeywordsBonnaya ciliataLinderniaceaePhytochemicalPlant-based drug discoveryTorenia crustacea ‹ Hedychium spicatum (Shati): A Comprehensive Review of its Pharmacological Activities and Phytochemical Constituents up Investigating the Expression of Apoptosis and Metastasis Genes in Satureja khuzistanica Along with Nisin and Doxorubicin in Colorectal Cancer ›